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The STAT3 transcription factor plays a central role in a wide range of cancer types where it is over-
expressed. Previously, phosphorylation of this protein was thought to be a prerequisite for direct
binding to DNA. However, we have now shown complete binding of a puriﬁed unphosphorylated
STAT3 (uSTAT3) core directly to M67 DNA, the high afﬁnity STAT3 target DNA sequence, by a protein
electrophoretic mobility shift assay (PEMSA). Binding to M67 DNA was inhibited by addition of
increasing concentrations of a phosphotyrosyl peptide. X-ray crystallography demonstrates one
mode of binding that is similar to that known for the STAT3 core phosphorylated at Y705.
Structured summary of protein interactions:
pSTAT3btc and pSTAT3btc bind by molecular sieving (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The STAT (signal transducer and activator of transcription) pro-
teins are transcription factors that modulate a number of cellular
functions [1]. These proteins can exist as monomers, dimerise to
form homodimers, or form heterodimers with other family mem-
bers [2,3]. STAT3 induces the transcription of genes that control
differentiation, inﬂammation, proliferation, and tumour cell inva-
sion [4,5]. Its over-expression has been implicated in many tumour
types [6,7]. According to the original paradigm, cytokines such as
interleukin-6 and interferon stimulate the phosphorylation of a
speciﬁc tyrosine residue of STAT3 (Tyr 705), which confers the abil-ity to sequentially form homodimers that accumulate in the nu-
cleus, and bind to its consensus DNA sequences [2,4,5]. A
number of post-translational modiﬁcations have also been identi-
ﬁed for STAT3, some believed to control dimerisation, others
affecting nuclear import/export or DNA binding. Understanding
the factors controlling these events, particularly the role of phos-
phorylation is critical for delineating cell signaling cascades and
the development of inhibitors for therapeutic use.
It has been previously reported that phosphorylation is not a
pre-requisite for nuclear transport of STAT3, which is dependent
on Ran, importin a3 and beta-1 [8,9]. Based on results from a
Y705F mutant, a novel mechanism has been suggested whereby
unphosphorylated STAT3 (uSTAT3) can have signiﬁcant transcrip-
tional control over the expression of genes such as RANTES, IL6,
IL8, MET and MRAS, which do not respond directly to phosphory-
lated STAT3 (pSTAT3) [10,11]. Some uSTAT3-responsive genes have
kappa B elements, and these genes are activated by a transcription
factor complex formed when uSTAT3 binds to unphosphorylated
NFjB [11] and not directly to DNA. Some uSTAT3-mediated gene
expression is, however, clearly mediated by an NFjB-independent
mechanism [11]. Recently, using a 100-fold molar excess, the uS-
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directly to a GAS consensus sequence, and also to AT-rich hairpin
and cruciform DNA structures by atomic force microscopy [12],
furthermore direct binding of the uSTAT1 core protein to its target
DNA sequence has been shown [13], where dimerisation was
thought to occur at the N-terminal domain. However, quantitative
binding of uSTAT3 core directly to DNA has not previously been
demonstrated.
Using a novel PEMSA method, we have shown almost quantita-
tive binding of puriﬁed uSTAT3 core directly to M67 dsDNA, a mod-
iﬁed c-fos sis inducible enhancer [14], at equimolar concentrations.
The unphosphorylated protein:DNA interaction found in the PEM-
SA studies has been conﬁrmed by X-ray crystallography, and sup-
ported by circular dichroism spectroscopy and molecular dynamics
simulations. Based on these new data, it can be postulated for the
ﬁrst time that unphosphorylated STAT3 can bind stoichiometri-
cally to a speciﬁc enhancer sequence and thereby contribute to
the expression of STAT3-dependent genes. STAT1 is known to drive
the constitutive expression of several genes through binding DNA
without tyrosine phosphorylation [13], and our observations for
STAT3 are consistent with this.2. Methods
2.1. Plasmid construction and expression
The expression construct pYFP-STAT3btc coding for the ﬂuores-
cent STAT3btc fusion protein (Supplementary Information, Fig. S1)
was generated by sub-cloning the PCR-ampliﬁed eYFP gene into
theNdeI restriction site at the 50-end of the STAT3btc gene. The Esch-
erichia coli strain Rosetta was transformed with these constructs to
prepare unphosphorylated protein YFP-uSTAT3btc and uSTAT3btc,
while the strain TKB1 [15] was used to prepare the phosphorylated
proteins YFP-pSTAT3btc and pSTAT3btc. A 10 L culture was induced
when the cells reached exponential phase (A600nm = 0.6) with 1 mM
IPTG, and the temperaturewas reduced from37 to21 C. The culture
was harvested by centrifugation 16 h later. To enable phosphoryla-
tion, the TKB1 cells were re-suspended in a tryptophan-free media
containing indole acrylic acid to induce theplasmidborneElkkinase,
and incubated at 21 C for 2 h before re-harvesting. A 45 g wet cell
pellet was typically obtained for each culture.
2.2. Protein puriﬁcation
Protein puriﬁcation was adapted from the method of Becker
et al. [16] in which the cells were ﬁrst lysed by sonication and then
centrifuged, but were not treated with PEI (polyethyleneimine)
prior to precipitation of the soluble protein (25% w/v ammonium
sulphate). Re-suspended protein was puriﬁed using HiTrap QFF,
and 98% pure STAT3btc was eluted in 0.1 M NaCl, 100 mM Tris
pH 8.5, 1 mM EDTA and 2 mM DTT. YFP-STAT3btc was eluted in
0.1 M NaCl, 20 mM Hepes pH 7.0, 10 mM MgCl2, 5 mM DTT.
2.3. PEMSA assays
Samples for PEMSA analysis were prepared in PEMSA buffer
containing bovine serum albumin (BSA) and sonicated salmon
sperm (SSS) to minimise non-speciﬁc binding (20 mM Hepes, pH
7.9, 40 mM KCl, 1 mMMgCl2, 0.03 mM EDTA, 0.03 mM EGTA,1 mM
DTT, 8% w/v glycerol, 33 lg/ml sonicated salmon sperm, 166 lg/ml
BSA). Typically, 3 lg YFP-pSTAT3btc or YFP-uSTAT3btc was diluted
to a ﬁnal volume of 15 ll. Double-stranded M67 DNAwas prepared
by dissolving the two oligonucleotides 50-TGCATTTCCCGTAAATCT-
30 and 50-AAGATTTACGGGAAATGC-30 in 100 mM NaCl at 100 nM
each, and annealing from 95 C for 5 min and slowly cooling toroom temperature. For the non-relevant double-stranded control,
the annealed DNA sequences were 50-CTAGCGAAAACTTGTATTTC-
CAGGGCG-30 and 50-GATCCGCCCTGGAAATACAAGTTTTCG-30.
Acrylamide PEMSAs were carried out at 150v using 10  8 cm
5% native polyacrylamide gels (25 mM Tris, pH 8.2, 22.5 mM Boric
acid, 2.5 mM EDTA, 2.5% glycerol) that had been pre-run for 2 h at
4 C. 10 ll samples were loaded with 8% ﬁnal concentration of
glycerol, but no loading dye. Agarose PEMSAs were carried out at
200v using 15  7 cm 2% agarose gels (25 mM Tris, pH 8.2,
22.5 mM Boric acid, 2.5 mM EDTA) at 4 C. 10 ll samples were
loaded with 8% glycerol, and no loading dye.
2.4. Crystallisation
The puriﬁed protein was concentrated and buffer exchanged
using a 10 kDa centifugal ﬁlter (Amicon Ultra) into 20 mM HEPES
pH 7.0, 200 mM NaCl, 10 mM MgCl2, 5 mM DTT, 0.5 mM PMSF to
a ﬁnal protein concentration of approximately 5 mg/ml, as deter-
mined by UV spectrophotometry (280 nm extinction coefﬁ-
cient = 88350). A 0.9 mM annealed DNA duplex was obtained by
overnight annealing.
Crystallizations used the hanging drop vapour diffusion meth-
od. Drops containing 1–2 ll of protein–DNA solution with the
same volume of well solution were equilibrated against 500 ll of
well solution, incubated at 4 C, with crystals typically appearing
within 48 h. Glycerol was used as a cryoprotectant, in an optimized
well solution of 5 mM MgSO4, 10 mM ammonium acetate, 35%
glycerol, 50 mM MES pH 6.0 and 300 mM NaCl. Association of du-
plex DNA with unphosphorylated STAT3btc resulted in high-qual-
ity diffracting crystals.
2.5. Structure solution and reﬁnement
Crystallographic data were collected at the Diamond Light
Source on beam line Io4-1, at a wavelength of 0.9785 Å, and
100 K. Processing and data reduction were carried out on site using
Xia2, an automated data processing tool within CCP4 [17]. The
starting uSTAT3btc model was derived from pSTAT3btc (PDB id
1BG1) with all solvent atoms and the phosphorylated tyrosine
705 residue removed. A simple rigid-body reﬁnement was sufﬁ-
cient to initiate reﬁnement, with subsequent reﬁnement and mod-
el building cycles performed using Refmac5 [18] and Coot [19].
Data collection and reﬁnement, along with deposition details, are
provided in SI Table 1.
2.6. Circular dichroism
All samples were diluted with binding buffer to an optimum
measurement concentration of 1.3 lM. The UV absorption and
CD spectra were acquired on an Applied Photophysics Chirascan
Plus spectrometer (Leatherhead, UK). The spectra were measured
in 10 and 0.5 mm rectangular cells in the regions 400–230 and
260–190 nm, respectively. The instrument was ﬂushed continu-
ously with pure evaporated nitrogen throughout the experiments.
Spectra were recorded using a 0.5 nm step size, a 1.5 s time-per-
point and a spectral bandwidth of 1 nm. The samples were stored
in the fridge prior and between repeat measurements. All spectra
were buffer baseline subtracted and measured at 25 C. The CD
data were smoothed with a window factor of 4 using the Sav-
itzky–Golay method for presentation purposes (see Supplementary
Information for data analysis).
2.7. Molecular dynamics simulations
The model of the pSTAT3btc:DNA complex was generated by
homology modeling, based on a pSTAT3 crystal structure (PDB id
Fig. 1. Schematic representation of the domains and size of the chimeric YFP-STAT3btc and truncated STAT3btc core constructs compared to the natural STAT3b.
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sion, the phosphoryl-group on Tyr 705 was removed to create a
regular Tyr residue. Both of the models included identical 17 bp
M67 dsDNA with single base overhanging 50-ends, corresponding
to the DNA sequence used in the pSTAT3 experimental study [16].
Both full-atom MD simulations used the GROMACS v 4.5.3 pro-
gram, employing the improved protein side-chain torsion poten-
tials from the AMBER parm99sb-ILDN force-ﬁeld, together with
the parmbsc0 force-ﬁeld (a reﬁnement of the AMBER parm99 force
ﬁeld for nucleic acids). Further AMBER parameters for the phos-
phorylated-Tyr residues were manually ported to GROMACS for
the simulations [20]. Further details are provided in the Supple-
mentary Information.
3. Results and discussion
To investigate the STAT3:DNA interaction using PEMSA, we de-
signed a YFP-STAT3btc construct in which the N-terminal 126 ami-
no acids of STAT3b were replaced with the spectral variants of GFP
(Green Fluorescent Protein) from the jellyﬁsh Aequorea victoria to
act as a reporter (Fig. 1). The STAT3b gene lacks the unstructured
C-terminal activation domain present in STAT3a and was used to
avoid aggregation of the puriﬁed protein [15,21]. The use of the Ro-
setta strain for expression of uSTAT3 proteins ensured no phos-
phorylation. Puriﬁed samples of phosphorylated YFP-pSTAT3btc
and unphosphorylated YFP-uSTAT3btc were fractionated by size
exclusion chromatography to determine their oligomeric state be-
fore addition of DNA. Fig. 2 shows that the puriﬁed unphosphory-
lated protein behaved as a monomer at 16 lM, while the
phosphorylated protein had double the molecular weight indicat-
ing a dimer. There was very little evidence of higher molecular
weight oligomers with this uSTAT3 core, although any large aggre-
gates would have been removed by a 0.22 lm ﬁlter before entering
the S6 gel ﬁltration column. A small peak at a lower molecularFig. 2. Size exclusion chromatograms of 160 lg YFP-pSTAT3btc (dimeric) and YFP-
uSTAT3btc (monomeric) following fractionation (100 ll samples) on a Superose™ 6
(S6) column calibrated with 4 standard protein markers (ovalbumin, 43 kDa;
conalbumin, 75 kDa; aldolase, 158 kDa; and thyroglobulin, 669 kDa). The Kav values
for YFP-pSTAT3btc and YFP-uSTAT3btc correlate to 250 and 100 kDa, respectively.weight was sometimes seen in gel ﬁltration and PEMSA experi-
ments, and was thought to represent a proteolytic product.
The double-stranded DNA used in the study was M67, a modi-
ﬁed c-fos sis-inducible enhancer sequence containing the cognate
binding site for STAT3. This is the same sequence used in structural
studies [16]. Duplex DNA was formed by annealing 50-
TGCATTTCCCGTAAATCT-30 with a complementary sequence (50-
AAGATTTACGGGAAATGC-30) containing a 50-single base overhang.
Acrylamide and agarose were investigated for use in the PEMSA
experiments and both gave similar results, although agarose PEM-
SAs were technically easier to perform and afforded a greater dis-
tance of separation between free and bound protein. The
acrylamide PEMSAs (Fig. 3) allowed faster migration of the protein
in the presence of DNA compared to protein alone (lanes 1 vs 3–5,
and 6 vs 9–10). In the absence of SDS in these native gels, the pro-
tein charge should be dominant, and so the negative charge of the
complex should be signiﬁcantly greater with DNA-binding leading
to faster migration despite increased mass. From the relative
migration of the bands in the acrylamide PEMSA, it follows that
the unphosphorylated protein (YFP-uSTAT3btc) alone migrates
slightly more slowly than its phosphorylated form (YFP-
pSTAT3btc). The addition of DNA signiﬁcantly increased the migra-
tion distance of both the YFP-uSTAT3btc and YFP-pSTAT3btc pro-
teins, clearly indicating that both have a strong interaction with
DNA. Observation of a single band (lanes 3–5 and 9–10) indicated
complete binding of the full-length ﬂuorescent protein to the DNA.
The YFP-pSTAT3btc:DNA complex ran as a tighter band compared
to the YFP-uSTAT3btc:DNA complex, suggesting a smaller range
for the hydrodynamic radius. The titration experiment showed that
the transition between free and DNA-bound migration bands (i.e.,
50% binding) occurred close to 0.3 lM M67 for phosphorylated
STAT3btc, and close to 0.9 lM M67 for unphosphorylated
STAT3btc. This difference may reﬂect a different stoichiometry,
but could also result from differences in afﬁnity, or a change in
the conformation or folding pattern of YFP-uSTAT3btc compared
to YFP-pSTAT3btc. The PEMSAs were all run with bovine serum
albumin and sonicated salmon DNA to minimize non-speciﬁc pro-
tein/DNA binding, and a further control using the non-relevant
double-stranded DNA failed to provide a gel shift (Supplementary
Information, Fig. S2).
A Western blot (Supplementary Information, Fig. S3) was per-
formed to further analyze the positions of STAT3btc in these gels
using the K15 antibody. This detected STAT3btc coincident with
the major ﬂuorescent bands, for both free and bound YFP-uS-
TAT3btc and YFP-pSTAT3btc, but did not recognize the faster
migrating minor ﬂuorescent bands of constant intensity seen in
Figs. 3 and 4, considered to be proteolytic fragments containing
YFP. It is noteworthy that YFP has a compact and stable b-barrel
arrangement which is known to be more resistant than STAT3 to
denaturation and proteolysis, and is therefore likely to persist.
The concentration of uSTAT3 used in PEMSAs (3 lM) was lower
than that used in gel ﬁltration (16 lM) where there was no evi-
dence of dimers, so it was initially assumed that the observed
YFP-uSTAT3btc:DNA complex either involved a transient dimeric
uSTAT3 core that had dimerized without phosphorylation and
which was stabilized in the DNA complex, or otherwise a mono-
meric uSTAT3 core interacted with DNA without dimerisation. To
Fig. 3. Polyacrylamide PEMSA showing the relative migration of YFP-uSTAT3btc and YFP-pSTAT3btc, and a clear shift for both samples in the presence of M67 DNA containing
the cognate recognition sequence. The PEMSA gels were illuminated using a blue light box.
Fig. 4. Agarose PEMSA to show inhibition of DNA binding. YFP-uSTAT3btc (lanes 3–10) and YFP-pSTAT3btc (Lanes 13–19) were pre-incubated with M67 dsDNA prior to
incubation with increasing concentration (lM) of the phosphotyrosyl peptide H2N-pY-LPQTV-NH2.
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for the site occupied by tyrosine 705 at the dimer interface, was
introduced to the PEMSA assay in order to evaluate its effect on
the YFP-uSTAT3btc:DNA and YFP-pSTAT3btc:DNA complexes
(Fig. 4). This peptidic sequence, H2N-pY-LPQTV-NH2, was derived
from the interleukin-6 receptor subunit gp130, and is known to
bind to the STAT3 SH2 domain with greater afﬁnity than the
homologous peptide H2N-pY-LKTKFI-NH2 [22], which was used
as a control (Supplementary Information, Fig. S4). We found that
H2N-pY-LPQTV-NH2 was able to decrease the DNA binding withunphosphorylated STAT3btc by 50% (DB50) at 30–100 lM, whereas
little if any inhibition was observed with phosphorylated
STAT3btc, even at 1000 lM (absolute DB50 values are higher than
for Ren et al. [22], due to higher substrate concentrations). This re-
sult was consistent with disruption of a dimeric uSTAT3 core inter-
action in the complex, leading to the observed decrease of DNA-
binding. The data does not however distinguish whether uSTAT3
cores dimerise before or after binding to DNA.
Crystallographic studies were carried out to further investigate
the interactions of uSTAT3 core protein and DNA. Prior to setting-
Fig. 5. (a and b) are cartoon representations of uSTAT3btc:DNA crystal structure (PDB id 4E68). Both panels show two copies of the asymmetric unit. Colour key:
green = coiled-coil domain; red = DNA binding domain; blue = SH2 domain; yellow = Y705 linker loop; orange = DNA. Tyrosine 705 is shown as ball-and-stick. The red arrow
on panel a indicates the viewing angle for panels b and d. (c) Shows the phosphorylated STAT3btc structure (1BG1) in purple overlaying the unphosphorylated STAT3btc
structure in gold highlighting the overall realignment of the tyrosine 705 residue. We observe a 2.0 Å displacement of the unphosphorylated tyrosine OH away from the
phosphate binding pocket forming a new ion–solvent interaction of distance 3.4 Å. The electron density 2Fo–Fc, is drawn at the 1r level. (d) Reveals the uSTAT3b3tc:DNA
interface in detail. The 2Fo–Fc, electron density map (grey) and Fo–Fc residual density map (red) highlight the quality of the reﬁned structure and accuracy of the atomic
coordinate data.
Fig. 6. Far-UV CD spectra of YFP-tagged STAT3btc (Y u-St3 and Y p-St3) and
untagged STAT3btc (u-St3 and p-St3) proteins.
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mixed with equimolar annealed DNA duplex (0.9 mM stock solu-
tion) at 4 C and incubated for 30 min, allowing formation of the
uSTAT3btc:DNA complex. The same duplex oligonucleotide
(M67) as used in the PEMSA experiments was selected for these
crystallization studies, as it contains the modiﬁed nine base-pair
consensus sequence to which pSTAT3btc dimers are known to bind
with higher afﬁnity [16].
A crystal structure of the uSTAT3btc:DNA complex was deter-
mined and reﬁned to 2.6 Å. This structure displays an isomorphous
mode of protein:DNA binding as seen in the equivalent phosphor-
ylated structure (PDB id 1BG1) [16], which involves two molecules
of uSTAT3btc binding to the duplex DNA via their DNA-binding do-
mains in a symmetric dimeric arrangement (Fig. 5a and b). This uS-
TAT3btc:DNA crystal structure therefore provides evidence in
support of the hypothesis that, under certain conditions, unphos-
phorylated STAT3 is able to bind to a target DNA sequence as a di-
mer. Structural alignment of the uSTAT3btc:DNA crystal structure
and the previously determined pSTAT3btc:DNA crystal structure
(PDB id 1BG1) reveals very little difference between these com-
plexes (RMSD = 0.66 Å for 558 Ca atoms). Realignment of the
unphosphorylated tyrosine can be seen in Fig. 5c, and the ends of
the alpha helices connecting the missing loop residues 184–194
are slightly more ordered. All other parts of the structures are
essentially unchanged. Fig. 5d clearly shows electron density for
the DNA and DNA-interacting residues of the protein. Residualdensity appearing between the DNA bases represents un-modelled
duplex DNA since the space group selection imposes a twofold
equivalence. Coordinates and structure factors are available from
the PDB (PDB id 4E68). A structural alignment with the monomeric
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Fig. 7. CD spectra of STAT3 proteins alone and in association with M67 dsDNA after subtraction of dsDNA alone. (A) uSTAT3btc; (B) YFP-uSTAT3btc; (C) pSTAT3btc; (D) YFP-
pSTAT3btc.
838 E. Nkansah et al. / FEBS Letters 587 (2013) 833–839STAT3 crystal structure that lacks the phosphotyrosine region (res-
idues 689–722) and is free from DNA (PDB id 3CWG) [23] reveals
only a slightly greater difference (RMSD = 0.95 Å for 500 Ca atoms).
Circular dichroism spectroscopy was used to provide informa-
tion about any possible folding effect of the YFP tag on DNA bind-
ing. Tagged and untagged uSTAT3 and pSTAT3 proteins were
studied, and the CD spectra in the far-UV region suggested that
all four were well-folded and adopted stable conformations
(Fig. 6). However, incubating the STAT3 proteins with 1 equiv of
the M67 dsDNA and recording the CD spectra after 5 min provided
signiﬁcant changes conﬁrming the association with dsDNA (Fig. 7).
A change in secondary structure was immediately obvious after
association with the DNA (see calculation of secondary structure
components in Supplementary Information). In each case, a small
decrease in a-helix component was observed with a corresponding
increase in b-sheet component.
A molecular dynamics simulation was carried out with the uS-
TAT3 monomer and uSTAT3 dimer in complex with M67 DNA to
obtain further information about the roles of the different uSTAT3
structures in association with their cognate DNA sequence. Molec-
ular modelling and full atomistic molecular dynamics (MD) simu-
lations were employed to systematically evaluate the binding free
energy for the association of both the phosphorylated (pSTAT3btc)
and unphosphorylated (uSTAT3btc) STAT3btc:DNA complexes.
Based on the MD ensemble structures, the interaction energies
and solvation free energies over the course of a 30 ns trajectory(1200 snapshots with 25 ps time-steps) were calculated by means
of the MM-PBSA (molecular mechanics (MM) Poisson Boltzmann/
Generalized Born surface area MM-GBSA) approach implemented
in AMBER 11, for STAT3:STAT3 association, as well as for STAT3:D-
NA association. The calculated binding free energy (DGbind) for the
STAT3:STAT3 interaction in the pSTAT3btc complex was
194.8 kcal/mol using the MMPBSA method, and 174.6 kcal/
mol using the MMGBSA method, while values of 95.2 kcal/mol
(MMPBSA) and 96.4 kcal/mol (MMGBSA), respectively, were ob-
tained for the uSTAT3 protein–protein interaction. Hence, the bind-
ing free energy of the protein–protein association was calculated to
be approximately twofold more favourable for pSTAT3btc than for
the uSTAT3btc complex. For the protein–DNA association, the cal-
culated binding energies (DGbind values; MMPBSA and MMGBSA
methods) were 137.1 and 88.2 kcal/mol for the pSTAT3btc:DNA
complex, and 140.1 and 89.8 kcal/mol for the uSTAT3btc:DNA
complex. These energies were in good qualitative agreement with
the experimental data described above.
4. Conclusion
We have demonstrated by PEMSA that unphosphorylated
STAT3 protein can bind almost quantitatively to M67 dsDNA. X-
ray crystallographic studies showed that the interaction with
DNA is very similar to that of phosphorylated STAT3. These obser-
vations have been further supported by CD spectroscopy and
E. Nkansah et al. / FEBS Letters 587 (2013) 833–839 839molecular dynamics simulations. The proposed mechanism for
transcriptional control of STAT3-dependent genes has generally
been based on the concept that phosphorylation of uSTAT3 is a pre-
requisite for DNA binding and transcriptional activation. The re-
sults reported here substantially support the hypothesis that
uSTAT3 as well as pSTAT3 can bind directly to DNA in order to play
a role in gene regulation. In the oncology area, all STAT3 drug dis-
covery research to date has focused on inhibitors targeted to the
phosphorylated STAT3 protein [24–26], and although to date there
have been no reports of the targeting of uSTAT3 by small molecules
for therapeutic purposes, Stark and co-workers [10,11,27] have re-
ported potential roles of uSTAT3 in oncogenesis and signalling in
cancer cells. Therefore, the results reported here support their ﬁnd-
ings and suggest that uSTAT3 could be a novel drug target in
oncology.
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